Endotracheal Tube Versus Laryngeal Mask Airway for Esophagogastroduodenoscopy
Endotracheal Intubation vs. Laryngeal Mask Airway for Esophagogastroduodenoscopy in Children
1 other identifier
interventional
84
1 country
1
Brief Summary
Esophagogastroduodenoscopy (EGD) is a relatively common procedure in pediatric patients undergoing evaluation for various gastrointestinal ailments. The procedure itself, with or without associated biopsies, is relatively short in length. Unlike adults, who regularly undergo this procedure with conscious sedation, children most often require general anesthesia. While safe and effective, endotracheal tracheal tube (ETT) intubation of children for EGD can result in delayed awakening and slow room turnover, particularly when intravenous medications are required for intubation. Laryngeal mask airway (LMA) is an alternative to intubation, which permits removal before full awakening. Although considered a safe alternative to tracheal intubation in appropriate cases, disadvantages of the LMA have been reported including kinking, occluding view of the surgical field, failure of placement requiring tracheal intubation, aspiration of gastric contents, desaturation, and laryngospasm. The study was designed to determine whether use of an LMA for EGD could reduce operating room time, while providing satisfactory conditions for the endoscopist, and an equivalent side effect and safety profile as compared to ETT in otherwise healthy children with gastrointestinal complaints
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Aug 2011
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
August 1, 2011
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 1, 2012
CompletedStudy Completion
Last participant's last visit for all outcomes
February 1, 2013
CompletedFirst Submitted
Initial submission to the registry
August 29, 2013
CompletedFirst Posted
Study publicly available on registry
September 6, 2013
CompletedResults Posted
Study results publicly available
May 2, 2016
CompletedMay 2, 2016
April 1, 2016
11 months
August 29, 2013
September 17, 2013
April 25, 2016
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Endoscopist Satisfaction
Endoscopist was surveyed to determine their satisfaction with each of the airway devices. Endoscopist used the following satisfaction scale for each patient, regardless of the airway device used: 1. The airway device did not interfere at all with the ability to perform the scope. 2. The airway device presented some interference with the scope, but not enough to cause difficulty. 3. The airway device made it difficult to perform the endoscopy. 4. The airway device prevented the endoscopy from being performed.
2 hours
Secondary Outcomes (1)
OR to Discharge (Min)
OR to discharge
Study Arms (2)
Largyngeal Mask Airway for EGD procedure
EXPERIMENTALPatients randomized to LMA to maintain airway through EGD procedure
Endotracheal Tube for EGD procedure
ACTIVE COMPARATORPatients were randomized to ETT to maintain airway for EGD procedure. This is the standard of care at this hospital
Interventions
Eligibility Criteria
You may qualify if:
- Scheduled for Esophagogastroduodenoscopy, with or without biopsies
- Have been informed of the nature of the study and informed consent has been obtained from the legally responsible
- Have provided assent in accordance with Institutional Review Board requirements
- Are able to complete pain assessment evaluations as determined by preoperative evaluations
You may not qualify if:
- Abnormal/difficult airway
- Symptomatic obstructive sleep apnea
- Risk of aspiration of stomach contents
- Upper respiratory infection within last 14 days
- Allergy to lidocaine or ondansetron
- EGD procedures associated with the need to exclude ondansetron administration
- BMI \>85th percentile for age
- Are unable to communicate effectively with study personnel
- Have a positive urine pregnancy test (menstruating females only at screening
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Riley Hospital for Children at IU Health
Indianapolis, Indiana, 46202, United States
Related Publications (1)
Acquaviva MA, Horn ND, Gupta SK. Endotracheal intubation versus laryngeal mask airway for esophagogastroduodenoscopy in children. J Pediatr Gastroenterol Nutr. 2014 Jul;59(1):54-6. doi: 10.1097/MPG.0000000000000348.
PMID: 24637966DERIVED
Results Point of Contact
- Title
- Nicole Horn, MD
- Organization
- IndianaU
Study Officials
- PRINCIPAL INVESTIGATOR
Micahel Acquaviva, MD
Indiana University
Publication Agreements
- PI is Sponsor Employee
- Yes
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, OUTCOMES ASSESSOR
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
August 29, 2013
First Posted
September 6, 2013
Study Start
August 1, 2011
Primary Completion
July 1, 2012
Study Completion
February 1, 2013
Last Updated
May 2, 2016
Results First Posted
May 2, 2016
Record last verified: 2016-04